Supernus Pharmaceuticals Inc (SUPN)

07:05 AM

Loomis Sayles & Co. L P Reduces Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

07:05 AM

Nov 25, 2024

Segall Bryant & Hamill LLC Invests $791,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 25, 2024

Nov 23, 2024

SUPN (Supernus Pharmaceuticals) Operating Margin % : 22.67% (As of Sep. 2024) - GuruFocus.com

Nov 23, 2024

Nov 23, 2024

Connor Clark & Lunn Investment Management Ltd. Has $6.70 Million Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 23, 2024

Nov 22, 2024

Pacer Advisors Inc. Buys 403,028 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 22, 2024

Nov 21, 2024

Supernus Pharmaceuticals (LTS:0LB2) EBITDA per Share : $2.79 (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Supernus Pharmaceuticals (FRA:S49) Degree of Operating Leve - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024

Nov 20, 2024

Mutual of America Capital Management LLC Sells 75,782 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 20, 2024

Nov 19, 2024

56,885 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Bought by State of New Jersey Common Pension Fund D - MarketBeat

Nov 19, 2024

Nov 19, 2024

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Purchased by Principal Financial Group Inc. - MarketBeat

Nov 19, 2024

Nov 17, 2024

Los Angeles Capital Management LLC Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 17, 2024

Nov 15, 2024

(SUPN) Technical Data - Stock Traders Daily

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Adjusts Stake in Supernus Pharmaceuticals Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

SUPNSupernus Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 14, 2024

Nov 14, 2024

Supernus Pharmaceuticals Inc (SUPN) Shares Gap Down to $36.57 on Nov 14 - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Have Supernus Pharmaceuticals Insiders Been Selling Stock? - Simply Wall St

Nov 14, 2024

Nov 13, 2024

Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference - The Manila Times

Nov 13, 2024

Nov 13, 2024

Supernus Pharmaceuticals CEO to Present at Jefferies London Healthcare Conference | SUPN Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

GSA Capital Partners LLP Acquires 43,086 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 13, 2024

Nov 12, 2024

Supernus Pharmaceuticals: Recently Launched Qelbree Is Powering Growth (NASDAQ:SUPN) - Seeking Alpha

Nov 12, 2024

Nov 09, 2024

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Director Georges Gemayel Sells 14,213 Shares - MarketBeat

Nov 09, 2024

Nov 09, 2024

Insider Selling: Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) SVP Sells 15,000 Shares of Stock - MarketBeat

Nov 09, 2024

Nov 09, 2024

Insider Selling: Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) CEO Sells 125,000 Shares of Stock - MarketBeat

Nov 09, 2024

Nov 08, 2024

Supernus Pharmaceuticals director sells shares worth $520,480 - Investing.com

Nov 08, 2024

Nov 08, 2024

Supernus Pharmaceuticals SVP Frank Mottola sells $554,700 in stock - Investing.com

Nov 08, 2024

Nov 08, 2024

Supernus Pharmaceuticals SVP Frank Mottola sells $554,700 in stock By Investing.com - Investing.com UK

Nov 08, 2024

Nov 08, 2024

Supernus: Q3 Earnings Snapshot - AOL

Nov 08, 2024

Nov 06, 2024

Supernus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

Earnings call: Supernus Pharmaceuticals reported a significant increase in total revenue - Investing.com Nigeria

Nov 05, 2024

Nov 05, 2024

Supernus Pharmaceuticals (NASDAQ:SUPN) Reaches New 1-Year High After Strong Earnings - MarketBeat

Nov 05, 2024

Nov 05, 2024

Supernus Pharmaceuticals Inc (SUPN) Q3 2024 Earnings Call Highli - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

Supernus Pharmaceuticals Inc (SUPN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates - MSN

Nov 05, 2024

Nov 04, 2024

Supernus Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024

Nov 04, 2024

Supernus Pharmaceuticals Q3 2024 Earnings: EPS of $0.69 Beats Es - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Nov 04, 2024

Nov 04, 2024

Supernus Announces Third Quarter 2024 Financial Results - GlobeNewswire

Nov 04, 2024

Nov 04, 2024

Supernus Pharmaceuticals (NASDAQ:SUPN) Posts Quarterly Earnings Results, Beats Estimates By $0.25 EPS - MarketBeat

Nov 04, 2024

Nov 04, 2024

Supernus Pharmaceuticals (FRA:S49) PE Ratio : 387.50 (As of Nov. 04, 2024) - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

Q3 2024 Supernus Pharmaceuticals Inc Earnings Call Transcript - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

Supernus Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024

Nov 04, 2024

Supernus Pharmaceuticals, Inc. Increases Earnings Guidance for the Year 2024 - Marketscreener.com

Nov 04, 2024

Nov 04, 2024

(SUPN) On The My Stocks Page - Stock Traders Daily

Nov 04, 2024

Nov 01, 2024

Macquarie Group Ltd Adjusts Stake in Supernus Pharmaceuticals Inc - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Stephens Investment Management Group LLC Buys 33,710 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 01, 2024

Nov 01, 2024

Dimensional Fund Advisors LP Expands Stake in Supernus Pharmaceu - GuruFocus.com

Nov 01, 2024

Oct 31, 2024

Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024 - The Manila Times

Oct 31, 2024

Oct 31, 2024

Supernus Presents Promising Data from Open-Label Phase 2a - GlobeNewswire

Oct 31, 2024